Centralized molecular analysis. Distributed clinical study centers. Shared commercial value.
FRAMEWORK
A global collaboration
built on local clinical
excellence
Local Clinical Study Centers
Germany
Hong Kong
Hungary
1.
Central Molecular Phenotyping Center
Partners send samples and pseudonymized data for standardized molecular phenotyping
→
3.
Local Clinical
Study Centers
Each partner establishes its own center and clinical cohort.
→
→
→
Central Molecular Phenotyping Center
PH 1.0
Development
2.
PH 1.0
Development
Integrated multi-partner data is used to build the PH1.0 health screening algorithm.
Shared Commercial Value
4.
Share Commercial
Value
Partners share the commercial value of PH1.0 and related outputs based on their contributions.
STRATEGY
A three-pillar
multi-Layer molecular profiling
Ultrashort-pulse infrared spectroscopy, mass spectroscopy, and AI integrated into a multi-layered health profile.
personalized molecular baselines
Establish a personalized blood molecular health reference range through longitudinal sampling.
global cohort program
A 10+ year longitudinal study across the globe, combining local clinical excellence with centralized molecular analysis to build PH1.0.